STAAR Surgical Recognizes Dr. Chung Eui Sang at 2026 Korea & Japan ICL Forum
STAAR Surgical presented an Appreciation Award to Dr. Chung Eui Sang of SNU Eye Clinic for his contributions to the development of the EVO ICL.
Stocks · News reference
Filed: 2026-10-05 AccNo: 0001193125-26-413763 Size: 242 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
STAAR Surgical presented an Appreciation Award to Dr. Chung Eui Sang of SNU Eye Clinic for his contributions to the development of the EVO ICL.
Analysts have increased the average 12-month price target for STAAR Surgical Company to $29.25, reflecting an 8% potential upside based on the November 4, 2026, closing price.
STAAR Surgical Company announced its financial results for the third quarter of 2026, reporting earnings per share of $0.11.
STAAR Surgical Company announced it will hold a conference call and webcast to discuss its third quarter 2026 financial results on November 4, 2026.
Stifel upgraded STAAR Surgical to Buy, while raising its price target, citing China momentum, EVO+ mix and upside to 2026-27 estimates.